Log in to save to my catalogue

Association between time in therapeutic range of tacrolimus blood concentration and acute rejection...

Association between time in therapeutic range of tacrolimus blood concentration and acute rejection...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9f47842de84a46579642550ae8dd0fd5

Association between time in therapeutic range of tacrolimus blood concentration and acute rejection within the first three months after lung transplantation

About this item

Full title

Association between time in therapeutic range of tacrolimus blood concentration and acute rejection within the first three months after lung transplantation

Publisher

London: BioMed Central Ltd

Journal title

Journal of pharmaceutical health care and sciences, 2022-10, Vol.8 (1), p.1-25, Article 25

Language

English

Formats

Publication information

Publisher

London: BioMed Central Ltd

More information

Scope and Contents

Contents

Background Tacrolimus is a key drug in immunosuppressive therapy following lung transplantation. The blood tacrolimus levels are likely to fluctuate in the early postoperative period, and failure to maintain the tacrolimus trough level in target ranges is a risk factor for rejection. However, there is little information about the relationship betwe...

Alternative Titles

Full title

Association between time in therapeutic range of tacrolimus blood concentration and acute rejection within the first three months after lung transplantation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9f47842de84a46579642550ae8dd0fd5

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9f47842de84a46579642550ae8dd0fd5

Other Identifiers

ISSN

2055-0294

E-ISSN

2055-0294

DOI

10.1186/s40780-022-00256-9

How to access this item